Market Research Report
Colorectal Cancer: Epidemiology Forecast to 2028
|Published by||GlobalData||Product code||918520|
|Published||Content info||47 Pages
Delivery time: 1-2 business days
|Colorectal Cancer: Epidemiology Forecast to 2028|
|Published: November 30, 2019||Content info: 47 Pages||
Colorectal cancer (CRC) is a cancer that occurs in the large intestine or large bowel (Centers for Disease Control and Prevention, 2019). Most CRCs start as abnormal growths known as polyps on the inner lining of the colon or rectum. Over time, some polyps may turn into cancer (American Cancer Society, 2018). Common symptoms of CRC are: blood in stool, stomach pain, aches or cramps that do not go away, weight loss, and a persistent change in bowel habit. CRC screening tests help to find colorectal cancer at an early stage and/or remove pre-cancerous polyps in the colon or rectum (American Cancer Society, 2018).
GlobalData epidemiologists utilized country-specific cancer registries, national databases, and robust peer-reviewed journal articles to build the forecast for the diagnosed incident cases and diagnosed prevalent cases of CRC in the 8MM.
The following data describes epidemiology of CRC. GlobalData epidemiologists forecast an increase in the diagnosed incident cases of CRC in the 8MM, from 827,242 cases in 2018 to 1,078,959 cases in 2028 at an AGR of 3.04% during the forecast period. The diagnosed prevalent cases of CRC in the 8MM are also expected to increase, from 5,307,305 cases in 2018 to 7,303,381 cases in 2028, at an AGR of 3.76% over the forecast period. CRC is more common in men than women and the risk of developing CRC increases with age. These trends are reflected in GlobalData's forecast for the diagnosed incident cases, with older age groups (ages ≥65 years) contributing the highest proportion of the incident cases in the 8MM.
The Colorectal Cancer Epidemiology series will allow you to -